Explore Idiopathic Pulmonary Fibrosis and more!

New, One-Step Cystic Fibrosis Test for Newborns May Be More Reliable Than Standard

IPF Therapy Capable of Halting Fibrosis Is Goal of Newly Launched Company, Pliant Therapeutics - Lung Disease News

Early Decline in 6-minute Walk Test Distance Predicts Pulmonary Arterial Hypertension Deterioration

Early decline in 6-minute walk test distance predicts Pulmonary Arterial Hypertension deterioration

Reata Announces Presentation of Initial Phase 2 Data on Bardoxolone Methyl for PAH at 2015 CHEST Meeting Lung Disease News

<span class="entry-title">Complexa’s CXA-10 To Be Tested as PAH Therapy in Upcoming Round of Phase 2 Trials</span><span class="entry-subtitle">Company plans to initiate phase 2 trials for multiple orphan indications in 2016</span>

Complexa's CXA-10 To Be Tested as PAH Therapy in Upcoming Round of Phase 2 Trials

<span class="entry-title">Complexa’s CXA-10 To Be Tested as PAH Therapy in Upcoming Round of Phase 2 Trials</span><span class="entry-subtitle">Company plans to initiate phase 2 trials for multiple orphan indications in 2016</span>

Pulmonary Fibrosis Foundation & Veracyte Partner To Advance Interstitial Lung Disease Survery Lung Disease News

Pulmonary Fibrosis Foundation & Veracyte Partner To Advance Interstitial Lung Disease Survery

Fatal Pulmonary Embolism Case Report Highlights Need For More Attention To Factitious Fever Risks Lung Disease News

<span class="entry-title">Nonin Medical’s COPD STEP™ Plan Set to be implemented in U.S hospitals This Month</span><span class="entry-subtitle">Nonin Medical, Inc. and Tri-anim Health Services, Inc. form partnership to implement the new COPD STEP™ Plan to improve disease management and quality of life</span>

Nonin Medical's COPD STEP™ Plan Set to be implemented in U.S hospitals This Month

FDA Approves Boehringer Ingelheim’s Stiolto Respimat as Maintenance Treatment for Patients With COPD

<span class="entry-title">Inoperable CTEPH Patients At Risk of Heart Failure May be Identified by Serum Bilirubin, 6-min Walk Distance Levels</span><span class="entry-subtitle">Researchers followed 77 consecutive patients with inoperable CTEPH and discovered markers of liver dysfunction in the blood carry prognostic value </span>

Inoperable CTEPH patients At Risk of Heart Failure May be Identified by Serum Bilirubin and 6-min Walk Distance Levels

<span class="entry-title">Inoperable CTEPH Patients At Risk of Heart Failure May be Identified by Serum Bilirubin, 6-min Walk Distance Levels</span><span class="entry-subtitle">Researchers followed 77 consecutive patients with inoperable CTEPH and discovered markers of liver dysfunction in the blood carry prognostic value </span>

If you've just been diagnosed with PH, you might be overwhelmed and unsure of the next steps to take. Here's a list to point you in the right direction.

4 Next Steps for the Newly Diagnosed

If you've just been diagnosed with PH, you might be overwhelmed and unsure of the next steps to take. Here's a list to point you in the right direction.

Read about the report that Tecfidera increases the numbers of regulatory B-cells, so-called Bregs, offering a potential mechanism of drug action.

MS Therapy Tecfidera Might Exert its Actions by Increasing Specific B-cells

Simple MS Blood Test Said to MS blood test? Be Able to Diagnose Disease at Symptom Onset. Quity Labs ready to launch series of early stage autoimmune disease diagnostic tests in

Bayer HealthCare Tests Chemical Libraries for New PAH Treatment

Bayer HealthCare Tests Chemical Libraries for New PAH Treatment

Pulmonary Hypertension, Ph, Libraries

Standards-Based Grading System

MyPHA Social Network Launched by Pulmonary Hypertension Association

Pinterest
Search